等待開盤 11-18 09:30:00 美东时间
-0.070
-0.61%
今日重点评级关注:康托·菲茨杰拉德:维持Lexeo Therapeutics"超配"评级,目标价从23美元升至37美元;摩根士丹利:维持Sana Biotechnology"超配"评级,目标价从12美元升至13美元
11-17 17:31
StoneX analyst Mark Zgutowicz upgrades Stagwell (NASDAQ:STGW) from Hold to Buy and announces $15 price target.
11-17 00:19
科技股抛售潮延续至新一周。由于投资者在英伟达即将公布备受瞩目的财报,以及人工智能公司Anthropic预计将在未来几天上市之前纷纷回避高风险资产,周一市场避...
11-16 21:29
As of Nov. 10, 2026, three stocks in the communication services sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days w...
11-10 21:48
今日重点评级关注:Canaccord Genuity:维持Viking Therapeutics"买入"评级,目标价从106美元升至118美元;Canaccord Genuity:维持Aclaris Therapeutics"买入"评级,目标价从10美元升至13美元
11-02 18:53
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• # Stagwell 2026财年第三季度业绩回顾摘要 ## 1. 财务业绩:**整体营收与利润:** - 营收(Revenue)达8.16亿美元,创公司历史新高 - 净营收(Net Revenue)达6.64亿美元 - 调整后EBITDA(Adjusted EBITDA)达1.448亿美元,创历史记录 - 调整后EBITDA利润率(Adjusted EBITDA Margin)达21.8%,创历史新高 - 调整后每股收益(Adjusted EPS)达0.34美元,创历史记录 **分部门净营收表现:** - 数字化转型(Digital Transfo
11-01 12:55
Needham analyst Laura Martin maintains Stagwell (NASDAQ:STGW) with a Buy and raises the price target from $10 to $12.
10-30 20:06
Stagwell 2026年第三季度业绩电话会:营收增长10%至8.16亿美元,调整后EBITDA增长25%,管理层上调了EBITDA及每股收益(EPS)指引。
10-29 21:55
Stagwell shares are trading lower after the company reported Q3 financial results. The company affirmed its FY26 sales guidance with its midpoint below estimates.
10-29 21:04
Stagwell (NASDAQ:STGW) reported quarterly earnings of $0.34 per share which beat the analyst consensus estimate of $0.31 by 9.68 percent. This is a 41.67 percent increase over earnings of $0.24 per share from the same period last year. The company reported quarterly sales of $816.027 million which b...
10-29 19:18